Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use – and failure to complete so may be grounds for compensation. Our lawyers are working hard to obtain those hurt by the drug the compensation they’re entitled to.
Whilst bleeding is actually a widespread complication connected with anticoagulants, it has been alleged that Xarelto is far more unsafe than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This implies that, inside the event of an emergency, individuals could be at danger for irreversible bleeding problems, such as life-threatening internal and gastrointestinal hemorrhaging.
If you or a loved a single suffered a significant bleeding occasion right after taking Xarelto, you might have legal recourse. For more info, speak to us these days to have your case reviewed, free of charge of charge.
Compensation Possibilities
xarelto administration-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in instances of death, funeral costs. Moreover, they may be searching for punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.